Literature DB >> 29770889

Autoregulation in the Neuro ICU.

Anson Wang1, Santiago Ortega-Gutierrez2, Nils H Petersen3.   

Abstract

PURPOSE OF REVIEW: The purpose of this review is to briefly describe the concept of cerebral autoregulation, to detail several bedside techniques for measuring and assessing autoregulation, and to outline the impact of impaired autoregulation on clinical and functional outcomes in acute brain injury. Furthermore, we will review several autoregulation studies in select forms of acute brain injuries, discuss the potential for its use in patient management in the ICU, and suggest further avenues for research. RECENT
FINDINGS: Cerebral autoregulation plays a critical role in regulating cerebral blood flow, and impaired autoregulation has been associated with worse functional and clinical outcomes in various acute brain injuries. There exists a multitude of methods to assess the autoregulatory state in patients using both invasive and non-invasive modalities. Continuous monitoring of patients in the ICU has yielded autoregulatory-derived optimal perfusion pressures that may prevent secondary injury and improve outcomes. Measuring autoregulation continuously at the bedside is now a feasible option for clinicians working in the ICU, although there exists a great need to standardize autoregulatory measurement. While the clinical benefits await prospective and randomized trials, autoregulation-derived parameters show enormous potential for creating an optimal physiological environment for the injured brain.

Entities:  

Keywords:  Bedside monitoring; Cerebral autoregulation; Critical care; Ischemic stroke; Traumatic brain injury, subarachnoid hemorrhage

Year:  2018        PMID: 29770889     DOI: 10.1007/s11940-018-0501-x

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  72 in total

1.  Continuous assessment of cerebrovascular autoregulation after traumatic brain injury using brain tissue oxygen pressure reactivity.

Authors:  Matthias Jaeger; Martin U Schuhmann; Martin Soehle; Jürgen Meixensberger
Journal:  Crit Care Med       Date:  2006-06       Impact factor: 7.598

2.  Increase in transcranial Doppler pulsatility index does not indicate the lower limit of cerebral autoregulation.

Authors:  H K Richards; M Czosnyka; H Whitehouse; J D Pickard
Journal:  Acta Neurochir Suppl       Date:  1998

Review 3.  Utility of transcranial Doppler ultrasound for the integrative assessment of cerebrovascular function.

Authors:  C K Willie; F L Colino; D M Bailey; Y C Tzeng; G Binsted; L W Jones; M J Haykowsky; J Bellapart; S Ogoh; K J Smith; J D Smirl; T A Day; S J Lucas; L K Eller; P N Ainslie
Journal:  J Neurosci Methods       Date:  2011-01-27       Impact factor: 2.390

4.  Identification and clinical impact of impaired cerebrovascular autoregulation in patients with malignant middle cerebral artery infarction.

Authors:  Christian Dohmen; Bert Bosche; Rudolf Graf; Thomas Reithmeier; Ralf-Ingo Ernestus; Gerrit Brinker; Jan Sobesky; Wolf-Dieter Heiss
Journal:  Stroke       Date:  2006-11-22       Impact factor: 7.914

5.  Cerebral autoregulation testing after aneurysmal subarachnoid hemorrhage: the phase relationship between arterial blood pressure and cerebral blood flow velocity.

Authors:  E W Lang; R R Diehl; H M Mehdorn
Journal:  Crit Care Med       Date:  2001-01       Impact factor: 7.598

6.  Predictors of global cognitive impairment 1 year after subarachnoid hemorrhage.

Authors:  Mellanie V Springer; J Michael Schmidt; Katja E Wartenberg; Jennifer A Frontera; Neeraj Badjatia; Stephan A Mayer
Journal:  Neurosurgery       Date:  2009-12       Impact factor: 4.654

7.  Cerebrovascular reactivity in patients with ruptured intracranial aneurysms.

Authors:  B Voldby; E M Enevoldsen; F T Jensen
Journal:  J Neurosurg       Date:  1985-01       Impact factor: 5.115

8.  Individualizing Thresholds of Cerebral Perfusion Pressure Using Estimated Limits of Autoregulation.

Authors:  Joseph Donnelly; Marek Czosnyka; Hadie Adams; Chiara Robba; Luzius A Steiner; Danilo Cardim; Brenno Cabella; Xiuyun Liu; Ari Ercole; Peter John Hutchinson; David Krishna Menon; Marcel J H Aries; Peter Smielewski
Journal:  Crit Care Med       Date:  2017-09       Impact factor: 7.598

9.  Dynamic cerebral autoregulation is transiently impaired for one week after large-vessel acute ischemic stroke.

Authors:  Nils H Petersen; Santiago Ortega-Gutierrez; Andrés Reccius; Arjun Masurkar; Amy Huang; Randolph S Marshall
Journal:  Cerebrovasc Dis       Date:  2015-02-03       Impact factor: 2.762

10.  Continuous monitoring of cerebrovascular pressure reactivity allows determination of optimal cerebral perfusion pressure in patients with traumatic brain injury.

Authors:  Luzius A Steiner; Marek Czosnyka; Stefan K Piechnik; Piotr Smielewski; Doris Chatfield; David K Menon; John D Pickard
Journal:  Crit Care Med       Date:  2002-04       Impact factor: 7.598

View more
  4 in total

1.  Too Aggressive Drop in Blood Pressure in a Hypertensive Male Leading to "Man-in-the-Barrel Syndrome".

Authors:  Chamara Dalugama; Achila Jayasinghe; Udaya Ralapanawa; Shamali Abeygunawardena; Thilak Jayalath
Journal:  Case Rep Neurol Med       Date:  2020-09-24

2.  Deviation From Personalized Blood Pressure Targets Is Associated With Worse Outcome After Subarachnoid Hemorrhage.

Authors:  Andrew Silverman; Sreeja Kodali; Sumita Strander; Emily J Gilmore; Alexandra Kimmel; Anson Wang; Branden Cord; Guido Falcone; Ryan Hebert; Charles Matouk; Kevin N Sheth; Nils H Petersen
Journal:  Stroke       Date:  2019-09-09       Impact factor: 7.914

Review 3.  Hemorrhagic Transformation After Ischemic Stroke: Mechanisms and Management.

Authors:  Ji Man Hong; Da Sol Kim; Min Kim
Journal:  Front Neurol       Date:  2021-11-30       Impact factor: 4.003

Review 4.  Hemodynamics and Hemorrhagic Transformation After Endovascular Therapy for Ischemic Stroke.

Authors:  Andrew Silverman; Sreeja Kodali; Kevin N Sheth; Nils H Petersen
Journal:  Front Neurol       Date:  2020-07-17       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.